Kate Farms Plant-Based Formulas Are Clinically Proven To Improve Tolerance And Help Patients Gain Weight

New Clinical Data Released at ASPEN Virtual Conference Demonstrates Positive Outcomes for Variety of Populations and Diseases

News provided by

Kate Farms

Mar 30, 2020, 09:05 ET

SANTA BARBARA, Calif., March 30, 2020 /PRNewswire/ -- Kate Farms, the #1 recommended plant-based formula prescribed to deliver vital medical nutrition to people with chronic diseases today announced the publication of new clinical data that demonstrates improved GI tolerance in a variety of populations and disease states. The four studies, originally accepted and slated to be presented as posters and oral presentations at ASPEN 2020, were released during the virtual conference.

Kate Farms' plant-based enteral formulas are made with easily digested pea protein and functional ingredients to support gut health; and without common allergens and artificial ingredients typically found in conventional formulas. In a concentrated effort to further demonstrate the effectiveness of their unique plant-based formulas, Kate Farms supported studies across multiple cohorts and chronic diseases.

"The totality of research, not just my own, indicates that plant-based formulas are effective in improving tolerance, supporting weight gain and improving patient outcomes in a variety of conditions via both oral and tube feeding," said one of the studies' co-authors and pediatric gastroenterologist Stanley Cohen , M.D. "Patients report feeling better, leading to improved adherence, as well."

Details on the positive findings from the clinical data include:

Title	Overview	View full abstract
Improved GI tolerance and weight gain in pediatric patients using plant-based enteral formulas	The purpose of this study was to assess the experience of pediatric patients consuming plant-based enteral formula at a single pediatric gastroenterology center. Researchers conducted a retrospective chart review, which included age, anthropometrics, medical history, method of administration, and nutritional regimen. A phone survey was administered to each patient's primary caregiver. Initially presented at NASGHAN in October 2019, this was the first study to demonstrate weight gain and tolerance with a plant-based formula in children.	Read Abstract
Patient-reported outcomes indicate plant-based enteral formula improves nutrition and gastrointestinal symptoms	An electronic survey consisted of questions on demographics, health outcomes while on a plant-based enteral formula and health outcomes while on the formula used previously, if applicable. A total of 392 respondents completed the survey. Results showed that patients who switched to Kate Farms reported improved digestive symptoms, feeling healthier, improved nutrition and weight gain or maintenance.	Read Abstract
Plant-based enteral nutrition tolerance and benefit in pediatric Crohn's disease" A Case Series	This case series reports the outcomes of three pediatric Crohn's disease patients in clinical remission who were started on pediatric peptide plant-based enteral nutrition in conjunction with Crohn's disease exclusion diet. Questionnaires were conducted, labs were analyzed, and anthropometrics were measured. Results included weight gain and increased BMI z-scores, as well as improved tolerance and adherence, compared to their previous formulas.	Read Abstract
Plant-Based Peptide Enteral Nutrition with Phytonutrients in a Pediatric Patient Status Post Bone Marrow Transplant: A Case Report	This case report documents the successful concomitant use of a plant-based, phytonutrient-containing enteral formula and immunosuppressive medications. A 3-year-old male with a history of Hemophagocytic Lymphohistiocytosis (HLH) and s/p Bone Marrow Transplant (BMT) was transitioned to a plant-based pediatric peptide enteral formula. Results included resolved symptoms of GI intolerance, weight gain, and no reported interactions with immunosuppressive medications.	Read Abstract

"Now, more than ever, patients, caregivers and medical providers turn to data to prove products are safe and effective. This research coupled with the thousands of testimonials from our Kate Farms family continue to demonstrate the effectiveness plant-based formulas can have to give more and more people the ability to thrive," said Cynthia Ambres, M.D., chief medical officer at Kate Farms.

The abstracts of these studies and case report are available online at www.katefarms.com/ForClinicians.

ABOUT KATE FARMS
Kate Farms was founded in 2012 by parents determined to save their daughter's life after a diagnosis of failure to thrive and is the #1 recommended plant-based formula. Kate Farms offers medical formulas for children and adults, to be used as sole source or supplemental nutrition, for oral or tube feeding. They are available nationally and eligible for insurance coverage with Medicare, Medicaid, and private insurance. Kate Farms formulas are made for tolerance with easily digested organic pea protein, fiber, and phytonutrients, and without common allergens or artificial sweeteners or flavors. Kate Farms can be accessed in more than 600 US hospitals, including the top children's hospitals; availability is increasing daily. Visit www.katefarms.com.

For more information, visit www.katefarms.com or follow the company on Instagram, Twitter, Facebook, or LinkedIn.

CONTACT:

[email protected]

or:

Errin Cecil-Smith
[email protected]
215.439.7776

SOURCE Kate Farms